| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Loss on issuance of financial instruments | -305,000 | 0 | - | - |
| Total other income (expense), net | 1,767,776 | -354,059 | -2,114,617 | 4,764,543 |
| Loss before (provision for) benefit from income taxes | -289,745 | -2,608,799 | -3,945,935 | -52,301,555 |
| (provision for) benefit from income taxes | 0 | 4,484 | 13,505 | -550,030 |
| Net loss | -289,745 | -2,613,283 | -3,959,440 | -51,751,525 |
| Net loss attributable to non-controlling interest | - | 0 | 0 | - |
| Net loss income attributable to stockholders | - | -2,613,283 | -3,959,440 | -51,751,525 |
| Basic loss per common share (in dollars per share) | -0.02 | -0.16 | -0.24 | -3.43 |
| Diluted loss per common share (in dollars per share) | -0.02 | -0.16 | -0.24 | -3.43 |
| Weighted average number of common shares outstanding, basic (in shares) | 16,549,357 | 16,422,651 | 16,312,468 | 15,077,548 |
| Weighted average number of common shares outstanding, diluted (in shares) | 16,549,357 | 16,422,651 | 16,312,468 | 15,077,548 |
VSEE HEALTH, INC. (VSEE)
VSEE HEALTH, INC. (VSEE)